咳嗽变异性哮喘的进展及治疗

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
杨千杭,崔金霞
文章摘要
咳嗽变异性哮喘(CVA)是慢性咳嗽的一种类型,其重要或唯一症状表现为咳嗽,同时可在病程中伴有气促、喘息等临床症状,对患者生活质量影响巨大,其目前主要治疗方法为吸入糖皮质激素(ICS)或ICS联合支气管舒张剂,如长效β2受体激动剂(LABA)。因此,该文通过对CVA的现阶段进展及治疗进行综述,介绍CVA的病因、临床表现、病理生理改变及其机制、诊断方法、治疗及疗程,以期为临床医生对CVA的诊断与治疗提供借鉴。
文章关键词
咳嗽变异性哮喘;治疗;进展
参考文献
[1] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(草案)[J].中华结核和呼吸杂志,2005,28(11):738-744. [2] CôtéA,Russell RJ,Boulet LP,et al.Managing chronic cough due to asthma and NAEB in adults and adolescents:CHEST guideline and expert panel report[J].Chest,2020,158(1):68-96. [3] 杭晶卿,孙碧雄,戴荷莲,等.上海浦东金桥地区4万人口支.气管哮喘流行病学调查[J].中国实用内科杂志,2002,22(10):616-617. [4] LAMBRECHT B N,HAMMAD H.The immunology of asthma[J].Nat Immunol,2015,16(1):45-56. [5] King G G,James A,Harkness L,et al.Pathophysiology of severe asthma:we’ve only just started[J].Respirology,2018,23(3):262-271. [6] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2021)[J].中华结核和呼吸杂志,2022,45(1):13-46. [7] Dicpinigaitis PV.Chronic cough due to asthma:ACCP evidence-based clinical practice guidelines[J].Chest,2006,129(1 Suppl):75s-79s. [8] NAKAJIMA T,NAGANO T,NISHIMURA Y.Retrospective analysis of the starting dose of combined ICS/LABA for coughvariant asthma and cough-predominant asthma[J].In Vivo,2022,36(2):949-953. [9] Lin J,Wang Z,Qiu C,et al.A multicenter,prospective,observational study on montelukast monotherapy or montelukast-based combin- ations treating cough variant asthma[J].Journal of Thoracic Disease,2020,12(11):6573-6585. [10] 摆永林,王燕.麻杏石甘汤合二陈汤加减治疗咳嗽变异性哮喘的临床研究[J].世界最新医学信息文摘,2018,18(52):86+97.
Full Text:
DOI